Outset Medical(US:OM) ZACKS·2025-02-19 23:15Core Insights - Outset Medical, Inc. reported a quarterly loss of $0.37 per share, better than the Zacks Consensus Estimate of a loss of $0.43, and an improvement from a loss of $0.59 per share a year ago, resulting in an earnings surprise of 13.95% [1] - The company generated revenues of $29.47 million for the quarter ended December 2024, exceeding the Zacks Consensus Estimate by 6.05%, although this represents a decline from $30.51 million in the same quarter last year [2] - Outset Medical shares have underperformed the market, losing approximately 18.2% year-to-date compared to the S&P 500's gain of 4.2% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is -$0.35 on revenues of $28.01 million, and for the current fiscal year, it is -$1.35 on revenues of $121.11 million [7] - The estimate revisions trend for Outset Medical is currently favorable, leading to a Zacks Rank 2 (Buy) for the stock, indicating expectations of outperformance in the near future [6] Industry Context - The Medical Info Systems industry, to which Outset Medical belongs, is currently ranked in the top 35% of over 250 Zacks industries, suggesting a positive outlook for stocks within this sector [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]